Latest Imaging SPECT System Evaluation Phase 1 (LISSE1)

Centre Hospitalier Régional d'Orléans

Status: Completed

Conditions: Thyroid Diseases; Pulmonary Embolism; Kidney Diseases; Parkinsonian Disorders; Neoplasms; Rheumatic Disease; Heart Diseases; Dementia; Parathyroid Diseases

Treatments: Radiation: Scintigraphy

Study type: Interventional

Funder types: Other

Identifiers

NCT04704349

CHRO-2019-12

Details and patient eligibility

About

Monocentric study for the evaluation of a whole body CZT scintigraphy system.

Full description

Monocentric evaluation of performances and clinical interest of a whole body scintigraphic acquisition system with CZT digital detectors. Comparison of image quality and resolution of the new system compared to a reference one, on phantoms and during the acquisition of a wide variety of examinations.

Enrollment: 68 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients referred to our Nuclear Medicine department for bone, cardiac, pulmonary, thyroid, parathyroid, renal or cerebral perfusion scintigraphy or to DaTSCAN.

Exclusion criteria

• Under 18 years old patients.
• Pregnant women or at risk of pregnancy.
• Patients under guardianship
• Painful patient (EVA>4)
• Patients in whom a standard examination is not feasible (agitation).

Trial design

Primary purpose: Other

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

68 participants in 1 patient group

Scintigraphy acquisitions

Experimental group

Description:

All patients will undergo scintigraphy on 2 distinct devices and the images obtained will be compared.

Treatment:

Radiation: Scintigraphy